NICE Guidelines For FeNO Testing Recommend Bedfont NObreath

The final diagnostics guidance on Measuring fractional exhaled nitric oxide concentration in asthma, recommending the use of Bedfont NObreath® have now been published

by Niki Carter | Thursday 3 April 2014

Bedfont_NOBreath.jpg
The Bedfont NObreath® is mentioned in new guidance recommending the use of simple, non-invasive testing to help diagnose and treat asthma. The report is produced by NICE, the National Institute for Health and Care Excellence.

Jason Smith, Commercial Manager at Bedfont Scientific said “The NObreath® monitor enables doctors, asthma specialists, GP’s and respiratory specialists to comply with ATS and ERS guidelines when testing for FeNO levels in asthma patients. Asthma patients can easily be tested and correctly assessed, thus saving time and reducing costs.

The battery powered monitor has been specifically designed to be highly portable. A large graphical colour touch screen and rapid start-up allows easy use by people of all ages.”

CONTACT

Jason Smith
Bedfont Scientific Ltd
ask@bedfont.com
www.bedfont.com
+44 (0) 1622 851122

Thursday 3 April 2014 / file under Healthcare | Medical